Results 51 to 60 of about 47,941 (305)

Postpartum hemorrhage prevention in Nepal: a program assessment

open access: yesBMC Pregnancy and Childbirth, 2017
Background In 2009, the Nepal Ministry of Health and Population launched a national program for prevention of postpartum hemorrhage (PPH) during home births that features advance distribution of misoprostol to pregnant women.
Swaraj Pradhan Rajbhandari   +7 more
doaj   +1 more source

Arterial dysgenesis and limb defects : Clinical and experimental examples [PDF]

open access: yes, 2017
Acknowledgements This article is dedicated to Dr David S. Packard Jr. With thanks to Dr John DeSesso, Dr Lewis B. Holmes, Dr Mark Levinsohn, Dr David S.
Hootnick, David R., Vargesson, Neil
core   +1 more source

A harm-reduction model of abortion counseling about misoprostol use in Peru with telephone and in-person follow-up: A cohort study

open access: yesPLoS ONE, 2018
Background In Peru, abortion is legal only to preserve the life and health of the woman. A non-profit clinic system in Peru implemented a harm-reduction model for women with unwanted pregnancy that included pre-abortion care with instructions about ...
D. Grossman   +6 more
semanticscholar   +1 more source

Estudio comparativo en el manejo médico del aborto terapéutico entre el uso de mifepristone más misoprostol y el uso de misoprostol solo

open access: yesRevista Peruana de Investigación Materno Perinatal, 2019
Objetivos: Evaluar las diferencias en el manejo médico del aborto terapéutico usando Mifepristone más Misoprostol comparado con el uso de Misoprostol solo.
Enrique Guevara-Ríos   +19 more
doaj   +1 more source

Comparison between clomiphene citrate and letrozole pretreatment with misoprostol versus misoprostol alone for induction of missed abortion in first trimester

open access: yesSVU - International Journal of Medical Sciences, 2023
Background: Missed Abortion is non-viable intrauterine pregnancy with either an empty gestational sac or a gestational sac contains an embryo without fetal heart activity.
Mostafa Mohamed Khodary   +2 more
doaj   +1 more source

Crystal structure of misoprostol bound to the labor inducer prostaglandin E2 receptor

open access: yesNature Chemical Biology, 2018
Misoprostol is a life-saving drug in many developing countries for women at risk of post-partum hemorrhaging owing to its affordability, stability, ease of administration and clinical efficacy. However, misoprostol lacks receptor and tissue selectivities,
Martin Audet   +18 more
semanticscholar   +1 more source

Pharmacokinetics of repeated doses of misoprostol [PDF]

open access: yes, 2009
BACKGROUNDMisoprostol is widely used in obstetrics and gynaecology for medical abortion, cervical priming and induction of labour. To aid the design of effective and safe regimens, we have investigated the pharmacokinetic parameters after the vaginal or ...
Ho, PC, Lee, SWH, Schweer, H, Tang, OS
core   +1 more source

Termination of pregnancy for medical indications: A 14‐year analysis from a tertiary referral center

open access: yesInternational Journal of Gynecology &Obstetrics, EarlyView.
Abstract Objective This study aimed to evaluate the medical indications for termination of pregnancy, gestational age at termination, and methods used in our clinic. Methods This observational retrospective study included pregnancy terminations after 10 weeks of gestation for medical indications between 2010 and 2024.
Yasemin Dogan   +5 more
wiley   +1 more source

A Pill in the Lifeworld of Women in Burkina Faso: Can Misoprostol Reframe the Meaning of Abortion

open access: yesInternational Journal of Environmental Research and Public Health, 2019
In Burkina Faso, induced abortion is socially stigmatized, condemned, disapproved and legally restricted to cases of rape, incest, fetal malformation or endangerment to the life of the mother.
Seydou Drabo
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy